VP, Gout Core Asset Team (CAT) Lead

Company Description

At Sobi, we believe diversity drives innovation and inclusion creates stronger teams. We are committed to building a workplace where everyone feels valued and empowered to contribute.
If this role excites you but you’re unsure if you meet every requirement, we encourage you to apply. Your unique perspective and experiences could be exactly what we need. We look forward to hearing from you!

At Sobi, each person brings their unique talents to work as a team and make a difference. We are dedicated to developing and delivering innovative therapies to improve the lives of people who live with a rare disease. Our edge comes from our team of people and our commitment to patients.

Our mission and culture at Sobi North America get us excited to come to work every day, but here are a few more reasons to join our team:

• Competitive compensation for your work
• Generous time off policy
• Opportunity to broaden your horizons by attending popular conferences
• Emphasis on work/life balance
• Collaborative and team-oriented environment
• Making a positive impact to help ultra-rare disease patients who are in need of life saving treatments

Job Description

Role 

The VP - Gout Core Asset Team (CAT) Lead is a senior cross-functional executive accountable for defining and executing the global strategy for Sobi’s Gout portfolio (two pre-launch assets). This includes lifecycle management (LCM), regulatory and commercial readiness, and long-term value maximization across key markets — with the U.S. as the lead focus. The role orchestrates an integrated strategy and execution plan to ensure successful development, approval, and sustained growth of Sobi’s Gout assets globally. This role reports to Vice President, Head of U.S. Immunology and Global Gout Franchise 

Key Responsibilities 

Strategic Leadership 

• Define and lead the global asset strategy for the Gout portfolio, aligned with corporate priorities. 

• Develop and maintain a high-quality Integrated Project Plan (IPP), including resourcing and budget. 

• Drive lifecycle management (LCM) to extend product value and optimize portfolio performance. 

• Contribute to portfolio-level prioritization and resource allocation across Sobi’s immunology pipeline. 

• Ensure readiness and execution of U.S. regulatory submissions and approvals. 

• Align evidence generation plans with asset strategy, guiding clinical, medical, and real-world data priorities. 

• Assess ex-U.S. markets to identify viable pathways and develop focused geographic launch plans. 

• Engage and build relationships, in coordination with Medical, with select top-KOLs to inform the strategy  

Cross-Functional Orchestration 

• Lead and develop the Core Asset Team (CAT), integrating expertise from R&D, Medical Affairs, TechOps, Commercial, and Project Management. 

• Partner closely with regional and functional leaders to ensure alignment between global strategy and local execution. 

• Ensure effective coordination between CAT members and their respective functional asset teams to drive execution of functional plans. 

• Collaborates closely with executive leadership and cross-functional teams across R&D, Medical Affairs, Market Access, Regulatory, TechOps, and Commercial to ensure strategic alignment and execution. 

• Collaborate with Alliance Management to ensure effective partnerships and joint governance. 

Operational Excellence 

• Build the investment cases and ensure budgets within approved guardrails. 

• Coordinate and oversee CAT members' strategy execution, leveraging functional expertise. 

• Prepare for and represent the asset in ExCom Portfolio Reviews and other key decision forums. 

• Lead proactive scenario and mitigation planning to manage strategic, regulatory, and commercial risks impacting asset value. 

• Identify risks and implement corrective actions early, escalating to governance committees as needed. 

• Maintain a single source of truth for asset data and performance metrics. 

Market & Commercial Focus 

• Partner with U.S. and regional teams to ensure launch readiness, assess ex-U.S. market potential, and maintain consistent launch excellence where applicable. 

• Collaborate with Insights & Analytics to inform strategy and pre-launch planning. 

• Translate market insights into actionable strategies for differentiation and growth.